MedPath

台山市新宁制药有限公司

Ownership
-
Established
2005-06-24
Employees
-
Market Cap
-
Website
www.chinaxnp.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Phenformin Hydrochloride

Product Name
盐酸苯乙双胍
Approval Number
国药准字H44020345
Approval Date
Jul 3, 2015
NMPA

Tetracycline Tablets

Product Name
四环素片
Approval Number
国药准字H44020355
Approval Date
Apr 28, 2014
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H10960049
Approval Date
Dec 26, 2013
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H44020334
Approval Date
Dec 18, 2013
NMPA

Sulfamidine Tablets

Product Name
磺胺脒片
Approval Number
国药准字H44020304
Approval Date
Dec 18, 2013
NMPA

Tetracycline Hydrochloride Capsules

Product Name
盐酸四环素胶囊
Approval Number
国药准字H44020156
Approval Date
Dec 18, 2013
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H44020300
Approval Date
Dec 18, 2013
NMPA

Taballae Rhenfforinnydrochloridi

Product Name
盐酸苯乙双胍片
Approval Number
国药准字H44020357
Approval Date
Dec 18, 2013
NMPA

Sulfadimidine Tablets

Product Name
磺胺二甲嘧啶片
Approval Number
国药准字H44020333
Approval Date
Dec 18, 2013
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H44020295
Approval Date
Dec 18, 2013
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.